🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Radica Z. Alicic

Providence Regional Medical Center Everett

ORCID: 0000-0002-5437-5700

Also affiliated with Providence College, University of Washington, Inland Northwest Health Services, Providence Health & Services

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.558Author DataRank

Indexed papers

3in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Social Determinants of Health and Risk for Long COVID in the U.S. RECOVER-Adult Cohort

Annals of Internal Medicine(2025)10.7326/annals-24-01971
Top 47%
0.386DataRank
Top 47%10 citations

L Santacroce, Ingrid V. Bassett, Tanayott Thaweethai, Radica Z. Alicic, Rachel Atchley +58 more

Papers

Driven by 17 papers — median percentile 33. Top paper: “Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19”.

Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19

medRxiv(2022)10.1101/2022.09.22.22280245
N/A
0.464DataRank · unranked
9 citations

Eyal Kedar, Kevin J. Anstrom, Matthew W. McCarthy, Emily R. Ko, Patricia Segura Nunez +38 more

Social Determinants of Health and Risk for Long COVID in the U.S. RECOVER-Adult Cohort

Annals of Internal Medicine(2025)10.7326/annals-24-01971
Top 47%
0.386DataRank
Top 47%10 citations

L Santacroce, Ingrid V. Bassett, Tanayott Thaweethai, Radica Z. Alicic, Rachel Atchley +58 more

Population-Level Risk Factors for Kidney Outcomes in IgA Nephropathy: The CURE-CKD Registry

Kidney Medicine(2025)10.1016/j.xkme.2025.100981
Top 67%
0.171DataRank
Top 67%2 citations

Lindsey M. Kornowske, Cami R. Jones, Kenn B. Daratha, Radica Z. Alicic, Christina Reynolds +6 more

KDOQI US Commentary on the KDIGO 2020 Clinical Practice Guideline for Diabetes Management in CKD

American Journal of Kidney Diseases(2022)10.1053/j.ajkd.2021.09.010
N/A
0DataRank · unranked
53 citations

Radica Z. Alicic, Christos Argyropoulos, Frank C. Brosius, Michael Mauer, Mark E. Molitch +4 more

Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United States

Kidney Medicine(2022)10.1016/j.xkme.2022.100590
N/A
0DataRank · unranked
3 citations

Radica Z. Alicic, Jenny I. Shen, Susanne B. Nicholas

Mechanisms and clinical applications of incretin therapies for diabetes and chronic kidney disease

Current Opinion in Nephrology & Hypertension(2023)10.1097/mnh.0000000000000894
N/A
0DataRank · unranked
27 citations

Joshua J. Neumiller, Katherine R. Tuttle, Radica Z. Alicic

Optimization of guideline-directed medical therapies in patients with diabetes and chronic kidney disease

Clinical Kidney Journal(2023)10.1093/ckj/sfad285
N/A
0DataRank · unranked
15 citations

Radica Z. Alicic, Katherine R Tuttle, Joshua J. Neumiller

Incretin Therapies for Patients with Type 2 Diabetes and Chronic Kidney Disease

Journal of Clinical Medicine(2023)10.3390/jcm13010201
N/A
0DataRank · unranked
10 citations

Joshua J. Neumiller, Radica Z. Alicic

Best Practices in the Use of Sodium–Glucose Cotransporter 2 Inhibitors in Diabetes and Chronic Kidney Disease for Primary Care

Diabetology(2023)10.3390/diabetology4040039
N/A
0DataRank · unranked
0 citations

Joshua J. Neumiller, Radica Z. Alicic, Tom Manley, Katherine R. Tuttle, Jay H. Shubrook

Combination therapy: an upcoming paradigm to improve kidney and cardiovascular outcomes in chronic kidney disease

Nephrology Dialysis Transplantation(2024)10.1093/ndt/gfae212
N/A
0DataRank · unranked
46 citations

Joshua J. Neumiller, Katherine R. Tuttle, Radica Z. Alicic

Incidence of chronic kidney disease among adults with prediabetes in the CURE ‐ CKD registry, 2013–2020

Diabetes Obesity and Metabolism(2025)10.1111/dom.16365
N/A
0DataRank · unranked
3 citations

O. Kenrik Duru, Cami R. Jones, Lindsey M. Kornowske, Kenn B. Daratha, Christina Reynolds +9 more

Clinical characteristics and CKD care delivery in African American and American Indian or Alaska Native patients: A real-world cohort study

BMC Nephrology(2025)10.1186/s12882-025-04263-4
N/A
0DataRank · unranked
1 citations

Radica Z. Alicic, Lindsey M. Kornowske, Cami R. Jones, Kenn B. Daratha, Christina Reynolds +6 more

Population Risk Predictors of Major Adverse Kidney Events in Patients with Focal Segmental Glomerulosclerosis from the CURE-CKD Registry

Research Square(2025)10.21203/rs.3.rs-5844460/v1
N/A
0DataRank · unranked
0 citations

Lindsey M. Kornowske, Cami R. Jones, Kenn B. Daratha, Radica Z. Alicic, Christina Reynolds +6 more

Glycemic Variability and KIM-1–Induced Inflammation in the Diabetic Kidney

Diabetes(2021)10.2337/dbi21-0021
N/A
0DataRank · unranked
12 citations

Radica Z. Alicic, Katherine R. Tuttle

Population risk predictors of major adverse kidney events attributed to focal segmental glomerulosclerosis from the CURE-CKD registry

BMC Nephrology(2025)10.1186/s12882-025-04334-6
Top 100%
0DataRank
Top 100%0 citations

Lindsey M. Kornowske, Cami R. Jones, Kenn B. Daratha, Radica Z. Alicic, Christina Reynolds +6 more

Incidence of Chronic Kidney Disease among Adults with Diabetes, 2015–2020

New England Journal of Medicine(2022)10.1056/nejmc2207018
N/A
0DataRank · unranked
101 citations

Cami R. Jones, Kenn B. Daratha, Alain K. Koyama, Susanne B. Nicholas, Radica Z. Alicic +6 more

Clinical Evidence and Proposed Mechanisms for Cardiovascular and Kidney Benefits from Sodium–Glucose Co-transporter-2 Inhibitors

touchREVIEWS in Endocrinology(2022)10.17925/ee.2022.18.2.106
N/A
0DataRank · unranked
23 citations

Fredrick J Lienhard, Radica Z. Alicic, Katherine R Tuttle, Joshua J. Neumiller